C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/19 (2006.01) A61P 35/00 (2006.01) C07K 14/52 (2006.01) C12N 15/19 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2411346
Novel biosynthetic oncolytic molecules are provided. The biosynthetic oncolytic molecules include functional domains derived from osteopontin. Preferred biosynthetic oncolytic molecules include an apoptotic domain derived from osteopontin. The oncolytic molecules of the present invention are capable of promoting cellular apoptosis. Accordingly, therapeutic uses are disclosed which feature the biosynthetic oncolytic molecules of the present invention.
L'invention concerne de nouvelles molécules oncolytiques biosynthétiques. Ces molécules oncolytiques biosynthétiques comprennent des domaines fonctionnels dérivés de l'ostéopontine. De préférence, ces molécules oncolytiques biosynthétiques comprennent un domaine apoptotique dérivé de l'ostéopontine. Les molécules oncolytiques de la présente invention peuvent favoriser l'apoptose cellulaire. En conséquence, l'invention concerne également des usages thérapeutiques faisant appel aux molécules oncolytiques biosynthétiques de la présente invention.
Ashkar Samy
Dehni Ghassan
Hikita Sherry
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Children's Medical Center Corporation
LandOfFree
Biosynthetic oncolytic molecules and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biosynthetic oncolytic molecules and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biosynthetic oncolytic molecules and uses therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1434346